Adult B-cell Acute Lymphoblastic Leukemia

1 clinical trials · Condition

Record	Firm	Date
This Clinical Trial is a Single-arm, Non-randomized Pilot Trial to Determine the Safety of Administering Autologous Anti-C19 Cells (ARI-0001) and the Feasibility of Local CAR-T Cell Production in Patients Over 18 Years of Age With Relapsed/Refractory (R/R) CD19+ Hematologic Malignancies, Including R (NCT07412405)	GUSTAVO SALGUERO	2026-09-01

Every clearance here is in the API, with alerts when new ones post.